Table 4.
Experimental therapeutics of Parkinson’s disease
MAOI: Safinamide |
DA: Sumanirole |
DA reuptake blockers: NS 2330 |
Antidyskinesia drugs: Sarizotan, istradefylline (KW-6002), fipamazole (JP-1730), levetiracetam |
Trophic drugs: GPI 1485, CERE-120, GDNF |
Neuroprotective drugs: CoQ10, TCH 346, CEP-1347, minocycline, creatine |
Surgery: fetal grafts, Spheramine® |
Abbreviations: DA, dopamine agonists; MAO, monoamine oxidases.